(Translated by https://www.hiragana.jp/)
Azenta, Inc. (AZTA) Stock Price, News, Quote & History - Yahoo Finance
NasdaqGS - Nasdaq Real Time Price USD

Azenta, Inc. (AZTA)

Compare
40.87 +0.05 (+0.12%)
At close: October 25 at 4:00 PM EDT
40.41 -0.46 (-1.13%)
Pre-Market: 7:44 AM EDT
Loading Chart for AZTA
DELL
  • Previous Close 40.82
  • Open 40.99
  • Bid --
  • Ask --
  • Day's Range 40.58 - 41.48
  • 52 Week Range 40.24 - 69.16
  • Volume 283,060
  • Avg. Volume 565,053
  • Market Cap (intraday) 2.031B
  • Beta (5Y Monthly) 1.47
  • PE Ratio (TTM) --
  • EPS (TTM) -2.86
  • Earnings Date Nov 11, 2024 - Nov 15, 2024
  • Forward Dividend & Yield --
  • Ex-Dividend Date Dec 2, 2021
  • 1y Target Est 58.00

Azenta, Inc. provides biological and chemical compound sample exploration and management solutions for the life sciences market in North America, Africa, China, the United Kingdom, rest of Europe, the Asia Pacific, and internationally. The company operates in two reportable segments, Life Sciences Products and Life Sciences Services. The Life Sciences Products segment offers automated cold storage solutions, consumables and instruments, controlled rate thawing devices, and temperature-controlled storage and transportation solutions. This segment also provides sample management solutions, such as consumable vials and tubes, polymerase chain reaction, plates, instruments for supporting workflows, and informatics. The Life Sciences Services segment provides genomic services, that includes gene sequencing and gene synthesis services; and sample repository solutions, such as on-site and off-site sample storage, cold chain logistics, sample transport and collection relocation, bio-processing solutions, disaster recovery and business continuity, and biospecimen procurement services, as well as project management and consulting services for genomic analysis and the management and care of biological samples used in pharmaceutical, biotech, healthcare, clinical, and academic research, and development sectors. It serves a range of life science customers, including pharmaceutical companies, biotechnology companies, biorepositories, and research institutes. The company was formerly known as Brooks Automation, Inc. and changed its name to Azenta, Inc. in December 2021. Azenta, Inc. was founded in 1978 and is headquartered in Burlington, Massachusetts.

www.azenta.com

3,300

Full Time Employees

September 30

Fiscal Year Ends

Recent News: AZTA

View More

Performance Overview: AZTA

Trailing total returns as of 10/25/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

AZTA
37.26%
S&P 500
21.77%

1-Year Return

AZTA
19.05%
S&P 500
36.74%

3-Year Return

AZTA
62.34%
S&P 500
27.79%

5-Year Return

AZTA
2.18%
S&P 500
92.94%

Compare To: AZTA

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: AZTA

View More

Valuation Measures

As of 10/25/2024
  • Market Cap

    2.00B

  • Enterprise Value

    1.47B

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    3.48

  • Price/Book (mrq)

    1.00

  • Enterprise Value/Revenue

    2.24

  • Enterprise Value/EBITDA

    21.69

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -23.66%

  • Return on Assets (ttm)

    -1.59%

  • Return on Equity (ttm)

    -6.64%

  • Revenue (ttm)

    658.62M

  • Net Income Avi to Common (ttm)

    -156.38M

  • Diluted EPS (ttm)

    -2.86

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    595.84M

  • Total Debt/Equity (mrq)

    3.59%

  • Levered Free Cash Flow (ttm)

    35.28M

Research Analysis: AZTA

View More

Earnings Per Share

Consensus EPS
 

Revenue vs. Earnings

Revenue 172.81M
Earnings -6.58M
 

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell
 

Analyst Price Targets

43.00
58.00 Average
40.87 Current
79.00 High
 

People Also Watch